FGFR1 Gene Complete Identifier and Functional Mapping Reference

Provide a comprehensive cross-database identifier and functional mapping reference for human FGFR1. This should serve as a definitive lookup resource …

Provide a comprehensive cross-database identifier and functional mapping reference for human FGFR1. This should serve as a definitive lookup resource for researchers. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 1: GENE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Provide ALL gene-level database identifiers: - HGNC ID and approved symbol - Ensembl gene ID (ENSG) - NCBI Entrez Gene ID - OMIM gene/locus ID - Genomic location: chromosome, start position, end position, strand ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 2: TRANSCRIPT IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL transcript-level identifiers: - Ensembl transcripts: ALL ENST IDs with biotype (protein_coding, etc.) How many total transcripts? - RefSeq transcripts: ALL NM_ mRNA accessions Mark which is MANE Select (canonical clinical standard) - CCDS IDs: ALL consensus coding sequence identifiers For the CANONICAL/MANE SELECT transcript: - List ALL exon IDs (ENSE) with genomic coordinates - Total exon count ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 3: PROTEIN IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL protein-level identifiers: - UniProt accessions: ALL entries (reviewed and unreviewed) Mark the canonical reviewed entry - RefSeq protein: ALL NP_ accessions Protein domains and families: - List ALL annotated domains/families with identifiers - Include: domain name, type (domain/family/superfamily), and ID ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 4: STRUCTURE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Experimental structures: - List ALL PDB structure IDs - For each: experimental method (X-ray, NMR, Cryo-EM) and resolution - Total PDB structure count Predicted structures: - AlphaFold model ID and confidence metrics (pLDDT) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 5: CROSS-SPECIES ORTHOLOGS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List orthologous genes in key model organisms (where available): - Mouse (Mus musculus): gene ID, symbol - Rat (Rattus norvegicus): gene ID, symbol - Zebrafish (Danio rerio): gene ID, symbol - Fruit fly (Drosophila melanogaster): gene ID, symbol - Worm (C. elegans): gene ID, symbol - Yeast (S. cerevisiae): gene ID, symbol ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 6: CLINICAL VARIANTS & AI PREDICTIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Clinical variant annotations: - Total variant count in clinical databases - Breakdown by classification: Pathogenic, Likely Pathogenic, Uncertain Significance (VUS), Likely Benign, Benign - List TOP 50 pathogenic/likely pathogenic variants with: variant ID, HGVS notation, associated condition AI-based variant effect predictions: - Splice effect predictions: Total count List TOP 50 predicted splice-altering variants with delta scores - Missense pathogenicity predictions: Total count List TOP 50 predicted pathogenic missense variants with scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 7: BIOLOGICAL PATHWAYS & GENE ONTOLOGY ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Pathway membership: - List ALL biological pathways this gene participates in - Include pathway IDs and names - Total pathway count Gene Ontology annotations: - Biological Process: count and TOP 20 terms with IDs - Molecular Function: count and TOP 20 terms with IDs - Cellular Component: count and TOP 20 terms with IDs ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 8: PROTEIN INTERACTIONS & MOLECULAR NETWORKS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Protein-protein interactions: - Total interaction count - List TOP 50 highest-confidence interacting proteins with scores Protein similarity (evolutionary and structural): - Structural/embedding similarity: How many similar proteins? List TOP 20 with similarity scores - Sequence homology: How many homologous proteins? List TOP 20 with identity/similarity scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 9: TRANSCRIPTION FACTOR REGULATORY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene encodes a transcription factor: Downstream targets (genes regulated BY this TF): - Total target gene count - List TOP 50 target genes with regulation type (activates/represses) DNA binding profiles: - List ALL known binding motif IDs - Motif family classification Upstream regulators (TFs that regulate THIS gene): - List known transcriptional regulators with evidence type ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 10: DRUG & PHARMACOLOGY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene/protein is a drug target: Targeting molecules: - How many drug/compound molecules target this protein? - List TOP 30 molecules by development phase - Include: molecule ID, name, mechanism, highest development phase Clinical trials: - How many clinical trials involve drugs targeting this gene? - List TOP 20 trials with: trial ID, phase, status, intervention Pharmacogenomics: - Known drug-gene interactions affecting drug response - Dosing guidelines if any exist ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 11: EXPRESSION PROFILES ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Tissue expression: - Which tissues express this gene most highly? - List TOP 30 tissues with expression scores/levels - Note any tissue-specific or tissue-enriched patterns Cell type expression: - Which cell types show highest expression? - List TOP 30 cell types with expression scores - Note any cell type-specific patterns Single-cell expression data (if available): - Which single-cell datasets/experiments include this gene? - Notable cell population patterns ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 12: DISEASE ASSOCIATIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Mendelian/monogenic disease links: - What diseases are caused by mutations in this gene? - List ALL associated diseases with: disease name, disease ID, inheritance pattern, evidence level Phenotype associations: - What clinical phenotypes are associated with this gene? - List TOP 50 phenotype terms with IDs Complex trait associations (GWAS): - What traits/diseases are linked via genome-wide association studies? - List TOP 30 GWAS associations with: trait, study ID, p-value, effect size if available ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ FORMATTING REQUIREMENTS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ - Present each section with clear headers - Use tables for listing multiple items - Always include COUNTS for every category - For lists with >50 items: show total count + TOP 50 - For lists with <50 items: show ALL items - Always include database identifiers (IDs), not just names - Mark canonical/primary/reviewed entries where applicable - If a section has no data available, state "No data available" rather than omitting the section

Structured Data Sources

This answer was generated using Claude Opus 4.5 + BioBTree MCP, querying 32 biological databases.

Further analyze this answer or run your own queries with BioBTree MCP.

Datasets: alphafold, alphamissense, bgee, ccds, chembl_molecule, chembl_target, clinvar, collectri, diamond_similarity, ensembl, entrez, esm2_similarity, exon, gencc, go, gwas, hgnc, hpo, intact, interpro, mim, orphanet, ortholog, pdb, pharmgkb_gene, reactome, refseq, scxa, spliceai, string_interaction, transcript, uniprot
Generated: 2026-04-01 — For the latest data, query BioBTree directly via MCP or API.
View API calls (39)
FGFR1

FGFR1 - Comprehensive Cross-Database Identifier and Functional Mapping Reference

Section 1: Gene Identifiers Primary Gene Identifiers

DatabaseIdentifierDescription
HGNC IDHGNC:3688Approved symbol
HGNC SymbolFGFR1Fibroblast growth factor receptor 1
Ensembl GeneENSG00000077782Human gene
NCBI Entrez Gene2260NCBI gene ID
OMIM136350Gene/Locus MIM
StatusApprovedProtein-coding gene
Genomic Location (GRCh38)
AttributeValue
Chromosome8
Cytogenetic Band8p11.23
Start Position38,400,215
End Position38,468,834
StrandMinus (-)
Biotypeprotein_coding
Gene Names and Aliases
TypeNames
Approved NameFibroblast growth factor receptor 1
Previous NamesFms-related tyrosine kinase 2
Previous SymbolsFLT2, KAL2
AliasesH2, H3, H4, H5, CEK, FLG, BFGFR, N-SAM, CD331
Gene Groups
  • Receptor tyrosine kinases
  • CD molecules
  • I-set domain containing

Section 2: Transcript Identifiers Summary

  • Total Ensembl Transcripts: 73
  • Protein-coding transcripts: 38
  • CCDS IDs: 9 Ensembl Transcripts (All 73)
Transcript IDBiotypeStartEnd
ENST00000447712protein_coding3841114338468635
ENST00000397091protein_coding3841113838468641
ENST00000703405protein_coding3841113838468834
ENST00000341462protein_coding3841114338468601
ENST00000326324protein_coding3841273238468616
ENST00000335922protein_coding3841273138468621
ENST00000356207protein_coding3841273038468616
ENST00000397103protein_coding3841293438457503
ENST00000397108protein_coding3841352238467724
ENST00000397113protein_coding3841272838467900
ENST00000413133protein_coding3842972038467712
ENST00000425967protein_coding3841164238467701
ENST00000434187protein_coding3842836338466695
ENST00000440174protein_coding3845744238463400
ENST00000525001protein_coding3842454938467842
ENST00000526742protein_coding3842615838467804
ENST00000529552protein_coding3842617438467845
ENST00000530568protein_coding3842801238466663
ENST00000532791protein_coding3841123138468622
ENST00000533668protein_coding3842454638467707
ENST00000683765protein_coding3841164238468601
ENST00000683815protein_coding3841273238468633
ENST00000684654protein_coding3841273238468633
ENST00000857933protein_coding3841272638468641
ENST00000857934protein_coding3841273038468635
ENST00000857935protein_coding3841284838468635
ENST00000857936protein_coding3841284838468635
ENST00000857937protein_coding3841284838468633
ENST00000857938protein_coding3841273038468128
ENST00000857939protein_coding3841284838467712
ENST00000857940protein_coding3841273238459212
ENST00000934569protein_coding3841114338468708
ENST00000934570protein_coding3841122938468634
ENST00000934571protein_coding3841281338468633
ENST00000934572protein_coding3841273638468255
ENST00000934573protein_coding3841113138466638
ENST00000965843protein_coding3841286938466638
ENST00000965844protein_coding3841286938461255
ENST00000397090retained_intron3842952138468150
ENST00000464163retained_intron3842274438424621
ENST00000466021retained_intron3841731338422044
ENST00000470826retained_intron3842331338468308
ENST00000474970retained_intron3842612738429811
ENST00000475621retained_intron3842170838426181
ENST00000496296retained_intron3842401738468635
ENST00000524528retained_intron3841296238420550
ENST00000526570retained_intron3841284838430820
ENST00000527114retained_intron3841477938420344
ENST00000527745retained_intron3841740738420044
ENST00000532386retained_intron3842468338430002
ENST00000533619retained_intron3841461338417514
ENST00000674217retained_intron3841791838424623
ENST00000674474retained_intron3841288038468152
ENST00000682398retained_intron3841296838417734
ENST00000682770retained_intron3842421738426585
ENST00000683132retained_intron3841292438416413
ENST00000683276retained_intron3842369238468601
ENST00000683795retained_intron3842372738468601
ENST00000683948retained_intron3841272838468601
ENST00000484370nonsense_mediated_decay3842617938457446
ENST00000487647nonsense_mediated_decay3841599338457446
ENST00000531196nonsense_mediated_decay3841346638415923
ENST00000619564nonsense_mediated_decay3841113938468834
ENST00000649678nonsense_mediated_decay3840021538467707
ENST00000674189nonsense_mediated_decay3841162738468165
ENST00000674235nonsense_mediated_decay3841953338428435
ENST00000674380nonsense_mediated_decay3841143138468132
ENST00000480571protein_coding_CDS_not_defined3846551438466196
ENST00000496629protein_coding_CDS_not_defined3846541338466663
ENST00000526688protein_coding_CDS_not_defined3841208538413976
ENST00000527203protein_coding_CDS_not_defined3842452838457476
ENST00000530701protein_coding_CDS_not_defined3842184338457532
ENST00000533301protein_coding_CDS_not_defined3840053638401683
RefSeq Transcripts (Human FGFR1 - chr8)
RefSeq IDTypeStatusMANE Select
NM_023110mRNAREVIEWEDYes (Canonical)
NM_015850mRNAREVIEWEDNo
NM_023105mRNAREVIEWEDNo
NM_023106mRNAREVIEWEDNo
NM_001174063mRNAREVIEWEDNo
NM_001174064mRNAREVIEWEDNo
NM_001174065mRNAREVIEWEDNo
NM_001174066mRNAREVIEWEDNo
NM_001174067mRNAREVIEWEDNo
NM_001354367mRNAREVIEWEDNo
NM_001354368mRNAREVIEWEDNo
NM_001354369mRNAREVIEWEDNo
NM_001354370mRNAREVIEWEDNo
NM_001410922mRNAREVIEWEDNo
CCDS IDs (9 total)
CCDS ID
CCDS6107
CCDS43730
CCDS43731
CCDS43732
CCDS55221
CCDS55222
CCDS94283
CCDS94284
CCDS94285
Exons for Canonical Transcript ENST00000447712 (18 exons)
Exon IDStartEndStrand
ENSE000019118653846798138468635-
ENSE000036107883845735638457534-
ENSE000013163153842968238429948-
ENSE000035516433842834638428435-
ENSE000036142503842792138428093-
ENSE000036839483842612238426245-
ENSE000035011673842450938424699-
ENSE000035104183842179738421941-
ENSE000035283893841953338419735-
ENSE000034897633841822838418373-
ENSE000036149463841787038417991-
ENSE000036440713841730638417416-
ENSE000035230103841587038416060-
ENSE000035763783841477938414901-
ENSE000035974753841455938414629-
ENSE000036809113841415238414289-
ENSE000036113373841391838414023-
ENSE000016303143841114338413804-

Section 3: Protein Identifiers Primary Protein Identifiers

DatabaseIdentifierDescription
UniProt (Canonical, Reviewed)P11362Fibroblast growth factor receptor 1
UniProt (Isoform)A0A0S2Z3Q6Unreviewed
UniProt (Isoform)A0A0S2Z3T4Unreviewed
UniProt (Isoform)A0A0S2Z3T9Unreviewed
UniProt (Isoform)A0A3B3ISD1Unreviewed
UniProt (Isoform)A0A6I8PRY1Unreviewed
UniProt (Isoform)A0A6I8PTV4Unreviewed
UniProt (Isoform)A0A804HIF1Unreviewed
UniProt (Isoform)A0A8I3B1S4Unreviewed
UniProt (Isoform)A0A994J419Unreviewed
UniProt (Isoform)B5A958Unreviewed
UniProt (Isoform)C9J1L5Unreviewed
UniProt (Isoform)C9J205Unreviewed
UniProt (Isoform)E7EU09Unreviewed
UniProt (Isoform)E9PKF2Unreviewed
UniProt (Isoform)E9PKV7Unreviewed
UniProt (Isoform)E9PKX3Unreviewed
UniProt (Isoform)E9PN14Unreviewed
UniProt (Isoform)E9PNM3Unreviewed
UniProt (Isoform)E9PQ40Unreviewed
UniProt (Isoform)H0YE20Unreviewed
Total UniProt Entries: 21 Canonical Protein Properties (P11362)
PropertyValue
Molecular Weight91,868 Da
Sequence Length822 amino acids
Alternative NamesBasic fibroblast growth factor receptor 1, Fms-like tyrosine kinase 2, N-sam, Proto-oncogene c-Fgr
RefSeq Protein Accessions
RefSeq ProteinTranscript
NP_075598NM_023110 (MANE Select)
NP_056934NM_015850
NP_075593NM_023105
NP_075594NM_023106
NP_001167534NM_001174063
NP_001167535NM_001174064
NP_001167536NM_001174065
NP_001167537NM_001174066
NP_001167538NM_001174067
NP_001341296NM_001354367
NP_001341297NM_001354368
NP_001341298NM_001354369
NP_001341299NM_001354370
NP_001397851NM_001410922
Protein Domains and Families (InterPro - 16 entries)
InterPro IDNameType
IPR050122RTKFamily
IPR016248FGF_rcpt_famFamily
IPR028174FGF_rcpt_1Domain
IPR000719Prot_kinase_domDomain
IPR001245Ser-Thr/Tyr_kinase_cat_domDomain
IPR020635Tyr_kinase_cat_domDomain
IPR003598Ig_sub2Domain
IPR003599Ig_subDomain
IPR007110Ig-like_domDomain
IPR013098Ig_I-setDomain
IPR013151Immunoglobulin_domDomain
IPR011009Kinase-like_dom_sfHomologous_superfamily
IPR013783Ig-like_foldHomologous_superfamily
IPR036179Ig-like_dom_sfHomologous_superfamily
IPR008266Tyr_kinase_ASActive_site
IPR017441Protein_kinase_ATP_BSBinding_site

Section 4: Structure Identifiers Summary

  • Total PDB Structures: 81
  • X-ray Diffraction: 77
  • Solution NMR: 2
  • Cryo-EM: 2 Experimental Structures (All 81 PDB entries)
PDB IDMethodResolutionTitle
1AGWX-RAY2.4 ÅTK domain with SU4984 inhibitor
1CVSX-RAY2.8 ÅDimeric FGF2-FGFR1 complex
1EVTX-RAY2.8 ÅFGF1 with FGFR1 ligand binding domain
1FGIX-RAY2.5 ÅTK domain with SU5402 inhibitor
1FGKX-RAY2.0 ÅTK domain
1FQ9X-RAY3.0 ÅTernary FGF2-FGFR1-heparin complex
1XR0NMR-SNT PTB domain interactions
2CR3NMR-First Ig-like domain
2FGIX-RAY2.5 ÅTK domain with PD173074
3C4FX-RAY2.07 ÅTK with 7-azaindole compound
3DPKX-RAY1.95 ÅcFMS TK with pyridopyrimidinone
3GQIX-RAY2.5 ÅActivated RTK with substrates
3GQLX-RAY2.8 ÅActivated RTK with substrates
3JS2X-RAY2.2 ÅKinase with thienylnicotinic acid
3KRJX-RAY2.1 ÅcFMS TK with imidazole compound
3KRLX-RAY2.4 ÅcFMS TK with furan compound
3KXXX-RAY3.2 ÅMutant FGFR1
3KY2X-RAY2.7 ÅKinase domain
3OJVX-RAY2.6 ÅFGF1 with FGFR1c ectodomain
3RHXX-RAY2.01 ÅKinase with ARQ 069
3TT0X-RAY2.8 ÅKinase with BGJ398 (Infigratinib)
4F63X-RAY2.55 ÅKinase with compound 1
4F64X-RAY2.05 ÅKinase with compound 6
4F65X-RAY2.26 ÅKinase with compound 8
4NK9X-RAY2.57 ÅKinase with pyrazolaminopyrimidine 1
4NKAX-RAY2.19 ÅKinase with pyrazolaminopyrimidine 2
4NKSX-RAY2.5 ÅKinase with pyrazolaminopyrimidine 3
4RWIX-RAY2.29 ÅV561M gatekeeper mutation, apo
4RWJX-RAY2.49 ÅWith AZD4547
4RWKX-RAY2.98 ÅV561M with AZD4547
4RWLX-RAY2.19 ÅWith E3810
4UWBX-RAY2.31 ÅKinase with JK-P5
4UWCX-RAY1.96 ÅKinase with JK-P3
4UWYX-RAY2.31 ÅApo structure
4V01X-RAY2.33 ÅWith ponatinib
4V04X-RAY2.12 ÅWith ponatinib
4V05X-RAY2.57 ÅWith AZD4547
4WUNX-RAY1.65 ÅWith AZD4547 (high resolution)
4ZSAX-RAY2.0 ÅKinase with compound 7n
5A46X-RAY2.63 ÅWith dovitinib
5A4CX-RAY2.09 ÅLigand complex
5AM6X-RAY1.96 ÅNative with inhibitor
5AM7X-RAY1.96 ÅMutant with inhibitor
5B7VX-RAY2.15 ÅWith CH5183284
5EW8X-RAY1.63 ÅWith JNJ-4275693
5FLFX-RAY2.58 ÅDisease linked mutation
5O49X-RAY1.91 ÅWith covalent inhibitor
5O4AX-RAY2.01 ÅWith covalent inhibitor
5UQ0X-RAY2.3 ÅWith fragment compound
5UR1X-RAY2.2 ÅWith SN37333
5VNDX-RAY2.2 ÅWith H3B-6527
5W21X-RAY3.0 ÅFGF23-FGFR1c-aKlotho ternary complex
5W59X-RAY2.5 ÅMonomeric FGF9 with FGFR1c
5Z0SX-RAY2.45 ÅWith novel inhibitor
5ZV2X-RAY2.86 ÅWith lenvatinib
6C18X-RAY2.3 ÅWith SN37115
6C19X-RAY2.12 ÅWith SN36985
6C1BX-RAY2.0 ÅWith SN37118
6C1CX-RAY2.15 ÅWith SN37116
6C1OX-RAY2.29 ÅWith FIIN-1
6ITJX-RAY1.99 ÅWith compound 3
6MZQX-RAY2.0 ÅWith TAS-120 (futibatinib) reversible
6MZWX-RAY2.2 ÅWith TAS-120 (futibatinib) covalent
6NVLX-RAY2.7 ÅWith acrylamide compound
6P68X-RAY2.9 ÅWith compound 22
6P69X-RAY2.2 ÅWith compound 11
7OZBX-RAY1.71 ÅWith compound 38
7OZDX-RAY1.82 ÅWith compound 34
7OZFX-RAY1.82 ÅWith compound 19
7TNHX-RAY2.7 ÅCSF1R kinase with DP-6233
7WCLX-RAY2.5 ÅWith pemigatinib
7YSHCRYO-EM2.74 ÅFGF23-FGFR1c-aKlotho-HS quaternary
8JMZX-RAY1.99 ÅWith sulfatinib
8JQICRYO-EM4.1 ÅPLCγ2 with FGFR1 kinase
8XLOX-RAY2.36 ÅWith CXF-007
8XZ7X-RAY1.75 ÅWith compound 10h
8Y22X-RAY2.79 ÅWith compound 9g
8YKIX-RAY2.79 ÅWith tasurgratinib
9CD5X-RAY2.94 ÅWith TYRA-300
9UHCX-RAY1.88 ÅWith compound 9p
9UHIX-RAY1.76 ÅWith compound 9o
AlphaFold Predicted Structure
Model IDpLDDT (Global)Sequence LengthFraction Very High Confidence
AF-P11362-F174.3064460.34 (34%)

Section 5: Cross-Species Orthologs

OrganismEnsembl Gene IDSymbolBiotype
Mouse (Mus musculus)ENSMUSG00000031565Fgfr1protein_coding
Rat (Rattus norvegicus)ENSRNOG00000016050Fgfr1protein_coding
Zebrafish (Danio rerio)ENSDARG00000011027fgfr1aprotein_coding
Zebrafish (Danio rerio)ENSDARG00000011190fgfr1bprotein_coding
Zebrafish (Danio rerio)ENSDARG00000104015fgfr1blprotein_coding
Fruit fly (Drosophila)No direct ortholog-See paralogs
Worm (C. elegans)No direct ortholog--
Yeast (S. cerevisiae)No ortholog--
Note: FGFR1 is a vertebrate-specific receptor. Invertebrates like Drosophila have related FGF receptors (heartless/breathless) but are not direct orthologs.

Section 6: Clinical Variants & AI Predictions ClinVar Summary

  • Total FGFR1 variants in ClinVar: 1,366+ Pathogenic/Likely Pathogenic Variants (TOP 50)
ClinVar IDHGVSClassificationCondition
16279c.755C>G (p.Pro252Arg)PathogenicPfeiffer syndrome
16303c.749G>A (p.Arg250Gln)PathogenicCraniosynostosis
235084c.749G>C (p.Arg250Pro)PathogenicCraniosynostosis
16296c.1825C>T (p.Arg609Ter)PathogenicHH2
224896c.1638C>A (p.Asn546Lys)PathogenicOncogenic
224897c.1966A>G (p.Lys656Glu)PathogenicOncogenic
132646c.790A>C (p.Asn264His)PathogenicOGD
132647c.1460G>A (p.Gly487Asp)PathogenicOGD
132648c.2084C>T (p.Thr695Ile)PathogenicCancer
16285c.499G>T (p.Ala167Ser)PathogenicHH2
16300c.2164C>T (p.Pro722Ser)PathogenicOGD
16301c.2292G>T (p.Gln764His)PathogenicOGD
377227c.1468G>A (p.Gly490Arg)PathogenicHH2
379237c.2152C>G (p.Arg718Gly)PathogenicOGD
265428c.1864C>G (p.Arg622Gly)PathogenicHH2
280606c.1431-1G>APathogenicSplicing
1065343c.745+2T>ALikely PathogenicSplicing
1074220c.979_983del (p.His327fs)PathogenicFrameshift
1184446c.2122G>T (p.Glu708Ter)PathogenicNonsense
1208776c.962_963del (p.Lys321fs)PathogenicFrameshift
1212943c.1936C>T (p.Arg646Trp)Likely PathogenicMissense
1338306c.2223del (p.Ser742fs)PathogenicFrameshift
1338919c.2187-1G>APathogenicSplicing
1341672c.1855-1G>APathogenicSplicing
1418780c.1265dup (p.Leu423fs)PathogenicFrameshift
1709350c.1969dup (p.Thr657fs)PathogenicFrameshift
1801171c.246_247del (p.Glu84fs)PathogenicFrameshift
1997422c.111del (p.Val38fs)PathogenicFrameshift
2011123c.625del (p.Arg209fs)PathogenicFrameshift
2029325c.780del (p.Leu261fs)PathogenicFrameshift
2097346c.1568_1569dup (p.Asp524fs)PathogenicFrameshift
2105298c.2048T>G (p.Val683Gly)PathogenicMissense
2136660c.1883A>G (p.Asn628Ser)PathogenicMissense
2136661c.302G>T (p.Cys101Phe)PathogenicMissense
2505374c.165_171del (p.Arg56fs)PathogenicFrameshift
2505375c.355dup (p.Ser119fs)PathogenicFrameshift
2505376c.551dup (p.Asn185fs)PathogenicFrameshift
2505377c.570G>A (p.Trp190Ter)PathogenicNonsense
2505378c.630T>A (p.Tyr210Ter)PathogenicNonsense
2505380c.925C>T (p.Gln309Ter)PathogenicNonsense
2505381c.1039dup (p.Ile347fs)PathogenicFrameshift
2505383c.1081+1G>TPathogenicSplicing
2505385c.1285-2A>GPathogenicSplicing
2505391c.1553-2A>GPathogenicSplicing
2505392c.1589C>G (p.Ser530Ter)PathogenicNonsense
2505394c.1684G>T (p.Glu562Ter)PathogenicNonsense
2505396c.1755C>A (p.Tyr585Ter)PathogenicNonsense
2505398c.1854+1G>APathogenicSplicing
2505443c.1889T>C (p.Leu630Pro)PathogenicMissense
3064126c.1988C>G (p.Pro663Arg)PathogenicMissense
AlphaMissense Predictions
  • Total Predicted Variants: 5,386 TOP 50 Predicted Pathogenic (score > 0.5)
VariantPositionAM ScoreClassification
K820N8:384136370.610Likely Pathogenic
K820I8:384136380.548Ambiguous
C806W8:384136790.514Ambiguous
Note: The C-terminal region shows predominantly benign predictions. Kinase domain and ligand-binding regions contain higher pathogenicity predictions. SpliceAI Predictions
  • Total FGFR1 Splice Variants Predicted: 5,160+ High-impact splice predictions occur predominantly at canonical splice sites (GT/AG) with delta scores approaching 1.0.

Section 7: Biological Pathways & Gene Ontology Reactome Pathways (22 total)

Pathway IDNameDisease Pathway
R-HSA-5654687Downstream signaling of activated FGFR1No
R-HSA-190370FGFR1b ligand binding and activationNo
R-HSA-190373FGFR1c ligand binding and activationNo
R-HSA-190374FGFR1c and Klotho ligand binding and activationNo
R-HSA-5654219Phospholipase C-mediated cascade: FGFR1No
R-HSA-5654688SHC-mediated cascade:FGFR1No
R-HSA-5654689PI-3K cascade:FGFR1No
R-HSA-5654693FRS-mediated FGFR1 signalingNo
R-HSA-5654726Negative regulation of FGFR1 signalingNo
R-HSA-5673001RAF/MAP kinase cascadeNo
R-HSA-109704PI3K CascadeNo
R-HSA-1257604PIP3 activates AKT signalingNo
R-HSA-375165NCAM signaling for neurite out-growthNo
R-HSA-445144Signal transduction by L1No
R-HSA-9758919Epithelial-Mesenchymal Transition during gastrulationNo
R-HSA-9793380Formation of paraxial mesodermNo
R-HSA-1839120Signaling by FGFR1 amplification mutantsYes
R-HSA-1839122Signaling by activated point mutants of FGFR1Yes
R-HSA-5655302Signaling by FGFR1 in diseaseYes
R-HSA-8853336Signaling by plasma membrane FGFR1 fusionsYes
R-HSA-2219530Constitutive Signaling by Aberrant PI3K in CancerYes
R-HSA-6811558PI5P, PP2A and IER3 Regulate PI3K/AKT SignalingNo
Gene Ontology Annotations Biological Process (55 terms) - TOP 20:
GO IDTerm
GO:0008543Fibroblast growth factor receptor signaling pathway
GO:0006468Protein phosphorylation
GO:0018108Peptidyl-tyrosine phosphorylation
GO:0046777Protein autophosphorylation
GO:0000165MAPK cascade
GO:0043410Positive regulation of MAPK cascade
GO:0008284Positive regulation of cell population proliferation
GO:0001525Angiogenesis
GO:0001501Skeletal system development
GO:0002062Chondrocyte differentiation
GO:0031175Neuron projection development
GO:0001764Neuron migration
GO:0001837Epithelial to mesenchymal transition
GO:0016477Cell migration
GO:0030326Embryonic limb morphogenesis
GO:0048863Stem cell differentiation
GO:0060038Cardiac muscle cell proliferation
GO:0048015Phosphatidylinositol-mediated signaling
GO:0042472Inner ear morphogenesis
GO:0007605Sensory perception of sound
Molecular Function (11 terms):
GO IDTerm
GO:0005007Fibroblast growth factor receptor activity
GO:0004713Protein tyrosine kinase activity
GO:0005524ATP binding
GO:0017134Fibroblast growth factor binding
GO:0008201Heparin binding
GO:0042802Identical protein binding
GO:0042803Protein homodimerization activity
GO:0042169SH2 domain binding
GO:0090722Receptor-receptor interaction
Cellular Component (12 terms):
GO IDTerm
GO:0005886Plasma membrane
GO:0016020Membrane
GO:0043235Receptor complex
GO:0005634Nucleus
GO:0005829Cytosol
GO:0031410Cytoplasmic vesicle
GO:0005576Extracellular region
GO:0098794Postsynapse
GO:0098978Glutamatergic synapse

Section 8: Protein Interactions & Molecular Networks STRING Protein-Protein Interactions

  • Total Interactions: 4,013+ TOP 50 Highest-Confidence Interactions (Score ≥ 750)
UniProt IDGeneInteraction Score
P11362FGFR1 (self)999
P55075-999
P05230FGF1998
P08620FGF4998
P09038FGF2998
P31371FGF9998
Q92913FGF21998
O15520FGF10997
O60258FGF18997
P10767FGF6997
P11487FGF3997
P12034FGF5997
P21781FGF7997
Q86Z14FGF23997
Q9GZV9FGF22997
Q9UEF7FGF20997
O76093FGF8996
O43320FGF16995
Q9HCT0FGF12995
Q9NP95FGF17995
Q8WU20FRS2987
Q9NSA1FRS3986
P13591NCAM1942
P22455FGFR4935
P23352FGFRL1935
P089085HT1A887
P31431SDC4887
Q14449GRB14886
P19022CDH2885
O95750FGFBP1884
P19174PLCG1868
Q9UBW7ZMYND8866
O75410TACC1864
Q15672TWIST1847
P14618PKM842
O14786NRP1823
Q9NVK5FGFR1OP2818
Q8NFJ6NRIP2817
P01116KRAS816
Q6X4W1NIBAN1804
P01133EGF800
O95684FGFR1OP788
Q9HC23FGFR1-IT1788
P42336PIK3CA778
P35222CTNNB1762
P30968GNRHR758
Q969F8CST3L756
P00338LDHA750
P16070CD44745
Q7Z7A1CNTRL741
IntAct Experimentally Validated Interactions
  • Total Curated Interactions: 232+ High-Confidence Direct Interactions (Score ≥ 0.8):
InteractionPartner GeneTypeScore
EBI-1028412FGF2Direct interaction0.910
EBI-22229196FGF2Direct interaction0.910
EBI-16017091PLCG1Phosphorylation0.900
EBI-16017120PLCG1Direct interaction0.900
EBI-22229123FGF1Direct interaction0.840
EBI-3647243FGF1Direct interaction0.840
Protein Sequence Similarity (DIAMOND)
  • Total Similar Proteins: 229+ TOP 20 by Sequence Identity:
UniProt IDDescriptionIdentity %Bitscore
A0M8S8FGFR1 isoform100.0%2803
P08581MET99.8%2813
A0M8R7FGFR1 isoform99.3%2784
P08069IGF1R97.7%2685
P10721KIT97.8%1840
P21802FGFR297.0%1615
P21803FGFR397.0%1611
P06213INSR99.5%2691
P35918VEGFR395.2%2582
P35917VEGFR295.9%2650
P35916VEGFR186.8%2385
P16234PDGFRA91.9%1964
P09619PDGFRB90.4%1933
O08775Fgfr1 (mouse)95.2%2575
P22182FGFRL180.6%1331
Structural/Embedding Similarity (ESM2)
  • Total Similar Proteins: 59 TOP 20 by ESM2 Similarity:
UniProt IDTop SimilarityAvg Similarity
B4HNW41.00000.9889
B4QC631.00000.9889
B4GBH01.00000.9887
P160920.99990.9910
P113620.99990.9908
Q6AWJ90.99990.9891
B4P5Q90.99990.9883
Q045890.99990.9910
A0JM200.99980.9834
Q8QFP90.99980.9833
Q498D60.99980.9843
Q031420.99980.9843
P551440.99980.9833
O351580.99970.9766
P218020.99970.9874
P218030.99970.9882
P184610.99970.9883
Q32MD90.99970.9765
P226070.99940.9866
P218040.99930.9914

Section 9: Transcription Factor Regulatory Data Note: FGFR1 is NOT a transcription factor, but is regulated by TFs. Upstream Regulators (TFs that regulate FGFR1)

  • Total TF Regulators in CollecTRI: 102+ TOP 50 Transcription Factors Regulating FGFR1:
TF GeneRegulationConfidence
E2F1ActivationHigh
E2F4UnknownHigh
KLF9ActivationHigh
KLF10RepressionHigh
TEAD4ActivationHigh
TEAD1ActivationLow
TGFB1Activation-
RB1Repression-
FGF2Repression-
ATOH1Repression-
APLNRepression-
SP1UnknownHigh
CEBPB-High
GATA3-High
DNMT1-High
EZH2-High
NFE2L2-High
RARA-High
PAX3-High
TCF3-High
TAL1-High
TBP-High
TFAP2A-High
ZBTB16-High
SP3-High
SP7-High
ATF1-High
ATOH8-High
HINFP-High
IRF1-High
IRF2-High
IRF3-High
KAT7-High
KDM5A-High
KDM5B-High
KDM5C-High
KMT2A-High
MBD2-High
AHR-Low
AP1-Low
ARNT-Low
ASCL2-Low
ASCL4-Low
DLX2-Low
DNMT3B-Low
FOXO3-Low
GATA4-Low
GLI2-Low
HOXD4-Low
ID1-Low

Section 10: Drug & Pharmacology Data ChEMBL Target Summary

Target IDTypeDescription
CHEMBL3650SINGLE PROTEINFibroblast growth factor receptor 1
CHEMBL2095217PROTEIN FAMILYFGFR family
CHEMBL2111439PROTEIN FAMILYVEGFR2/FGFR1 dual target
CHEMBL5291677PPICereblon/FGFR1
CHEMBL5291688PPIVHL/FGFR1
FDA-Approved Drugs Targeting FGFR1 (Phase 4)
ChEMBL IDDrug NameTypeApproved Indication
CHEMBL3545376ERDAFITINIBSmall moleculeFGFR-altered urothelial cancer
CHEMBL1852688INFIGRATINIBSmall moleculeCholangiocarcinoma with FGFR2 fusion
CHEMBL4297522PEMIGATINIBSmall moleculeCholangiocarcinoma
CHEMBL3701238FUTIBATINIBSmall moleculeCholangiocarcinoma
CHEMBL1171837PONATINIBSmall moleculeCML, Ph+ ALL
CHEMBL535SUNITINIBSmall moleculeRCC, GIST
CHEMBL1336SORAFENIBSmall moleculeHCC, RCC
CHEMBL1289601LENVATINIBSmall moleculeThyroid cancer, HCC
CHEMBL1289926AXITINIBSmall moleculeRCC
CHEMBL24828VANDETANIBSmall moleculeMedullary thyroid cancer
CHEMBL477772PAZOPANIBSmall moleculeRCC, STS
CHEMBL1289494TIVOZANIBSmall moleculeRCC
CHEMBL502835NINTEDANIBSmall moleculeIPF, NSCLC
CHEMBL1946170REGORAFENIBSmall moleculeCRC, GIST, HCC
CHEMBL1983268ENTRECTINIBSmall moleculeNTRK+ solid tumors
CHEMBL2105717CABOZANTINIBSmall moleculeRCC, HCC, MTC
CHEMBL3545311BRIGATINIBSmall moleculeALK+ NSCLC
CHEMBL608533MIDOSTAURINSmall moleculeAML with FLT3
CHEMBL1287853FEDRATINIBSmall moleculeMyelofibrosis
CHEMBL3622821UPADACITINIBSmall moleculeRA
CHEMBL5416410DASATINIBSmall moleculeCML, Ph+ ALL
CHEMBL2325741CAPIVASERTIBSmall moleculeHR+/HER2- breast cancer
CHEMBL1448NICLOSAMIDESmall moleculeAnthelmintic
Phase 3 Clinical Candidates
ChEMBL IDDrug NameType
CHEMBL223360LINIFANIBSmall molecule
CHEMBL2316582OLVEREMBATINIBSmall molecule
CHEMBL270995BRIVANIB ALANINATESmall molecule
CHEMBL274654ORANTINIBSmall molecule
CHEMBL276711SEMAXANIBSmall molecule
CHEMBL300138ENZASTAURINSmall molecule
CHEMBL377300BRIVANIBSmall molecule
CHEMBL4297190SURUFATINIBSmall molecule
CHEMBL483158ALISERTIBSmall molecule
CHEMBL484ADEFOVIRSmall molecule
CHEMBL491473CEDIRANIBSmall molecule
CHEMBL522892DOVITINIBSmall molecule
CHEMBL572881MOTESANIBSmall molecule
CHEMBL603469LESTAURTINIBSmall molecule
CHEMBL91829RUBOXISTAURINSmall molecule
PharmGKB
PharmGKB IDSymbolVIP GeneCPIC Guideline
PA28127FGFR1YesNo

Section 11: Expression Profiles Bgee Expression Summary

MetricValue
Expression PatternUbiquitous
Total Present Calls292
Total Absent Calls2
Total Conditions Tested294
Max Expression Score98.95
Average Expression Score90.66
Gold Quality Data Points275
TOP 30 Tissues by Expression Score
RankTissue/Cell TypeScoreQuality
1Buccal mucosa cell98.95Gold
2Stromal cell of endometrium98.88Gold
3Calcaneal tendon98.84Gold
4Right ovary98.59Gold
5Paraflocculus98.54Gold
6Left ovary98.49Gold
7Right coronary artery98.47Gold
8Left uterine tube98.44Gold
9Cerebellar hemisphere98.42Gold
10Right hemisphere of cerebellum98.38Gold
11Cerebellar cortex98.37Gold
12Cerebellum98.30Gold
13Descending thoracic aorta98.29Gold
14Body of pancreas98.25Gold
15Ascending aorta98.23Gold
16Thoracic aorta98.22Gold
17Aorta98.17Gold
18Popliteal artery98.16Gold
19Tibial artery98.15Gold
20Gall bladder98.11Gold
21Mucosa of stomach98.07Gold
22Lower esophagus muscularis98.06Gold
23Saphenous vein98.05Gold
24Lower esophagus98.02Gold
25Esophagogastric junction98.02Gold
26Colonic epithelium97.94Gold
27Omental fat pad97.90Gold
28Peritoneum97.89Gold
29Coronary artery97.89Gold
30Tibial nerve97.83Gold
Single-Cell Expression Atlas (SCXA) Datasets
DatasetDescriptionCells
E-MTAB-8142Human breast skin cells809,675
E-MTAB-7407Human fetal liver, skin, kidney473,803
E-CURD-126Normal and fibrotic lungs121,080
E-MTAB-9841Mammary epithelial cells92,071
E-MTAB-10855Lactating mammary gland74,404
E-MTAB-10018Naive/primed pluripotent stem cells37,007
E-MTAB-10885Human milk vs breast tissue28,628
E-MTAB-11121Retinal organoids22,253
E-MTAB-5061Human pancreas (normal & T2D)3,386
E-GEOD-93593H1 ESC differentiation1,733
E-ENAD-27Human islet cells1,145
E-CURD-7Adult breast epithelial cells867
E-ENAD-21Adult breast epithelial cells867
E-GEOD-75140Cerebral organoids734

Section 12: Disease Associations Mendelian/Monogenic Diseases (GenCC - 29 associations)

DiseaseOMIM/MONDOInheritanceClassification
Pfeiffer syndromeOMIM:101600ADDefinitive
Hypogonadotropic hypogonadism 2 ± anosmia (HH2)OMIM:147950ADDefinitive
Osteoglophonic dysplasia (OGD)OMIM:166250ADDefinitive
Hartsfield-Bixler-Demyer syndromeOMIM:615465ADDefinitive
Encephalocraniocutaneous lipomatosisOMIM:613001ADDefinitive
Jackson-Weiss syndromeOMIM:123150ADStrong
Kallmann syndromeORPHANET:478ADSupportive
Trigonocephaly (isolated)ORPHANET:3366ADSupportive
Septo-optic dysplasia spectrumORPHANET:3157ADSupportive
Tooth agenesisORPHANET:99798ADSupportive
HoloprosencephalyORPHANET:2162ARSupportive
Orphanet Disease Associations (17 total)
Orphanet IDDiseaseTypeGene Count
2117Hartsfield syndromeMalformation syndrome1
2645Osteoglophonic dysplasiaMalformation syndrome1
2396Encephalocraniocutaneous lipomatosisDisease2
478Kallmann syndromeClinical subtype22
432Normosmic congenital HHClinical subtype18
3157Septo-optic dysplasia spectrumMalformation syndrome7
3366Non-syndromic metopic craniosynostosisMorphological anomaly2
93258Pfeiffer syndrome type 1Clinical subtype2
99798OligodontiaMorphological anomaly12
168953Myeloid/lymphoid neoplasm with FGFR1 rearrangementDisease1
314950Primary hypereosinophilic syndromeDisease5
220386Semilobar holoprosencephalyClinical subtype18
93924Lobar holoprosencephalyClinical subtype16
280200Microform holoprosencephalyMalformation syndrome16
251576GliosarcomaHistopathological subtype12
251579Giant cell glioblastomaHistopathological subtype13
251615Pilomyxoid astrocytomaHistopathological subtype8
HPO Phenotype Associations (393+ terms) TOP 50 Associated Phenotypes:
HPO IDPhenotype
HP:0000006Autosomal dominant inheritance
HP:0000044Hypogonadotropic hypogonadism
HP:0000458Anosmia
HP:0000028Cryptorchidism
HP:0000054Micropenis
HP:0000252Microcephaly
HP:0000243Trigonocephaly
HP:0000175Cleft palate
HP:0000204Cleft upper lip
HP:0000316Hypertelorism
HP:0000347Micrognathia
HP:0000486Strabismus
HP:0000520Proptosis
HP:0000586Shallow orbits
HP:0000365Hearing impairment
HP:0000470Short neck
HP:0000508Ptosis
HP:0000568Microphthalmia
HP:0000238Hydrocephalus
HP:0000609Optic nerve hypoplasia
HP:0000164Abnormality of dentition
HP:0000677Oligodontia
HP:0000684Delayed eruption of teeth
HP:0000717Autism
HP:0000739Anxiety
HP:0000716Depression
HP:0000104Renal agenesis
HP:0000126Hydronephrosis
HP:0000125Pelvic kidney
HP:0000027Azoospermia
HP:0000134Female hypogonadism
HP:0000144Decreased fertility
HP:0000013Hypoplasia of uterus
HP:0000026Male hypogonadism
HP:0000047Hypospadias
HP:0000062Ambiguous genitalia
GWAS Associations (61 associations) TOP 30 GWAS Traits:
Study IDTraitP-valueMapped Gene
GCST007995Asthma (childhood onset)2e-65FLG/CCDST
GCST010985Allergic disease (age of onset)3e-82FLG/CCDST
GCST010984Allergic disease (multivariate)5e-82FLG/CCDST
GCST009718Eczema1e-64CCDST
GCST007798Asthma1e-30FLG/CCDST
GCST007994Asthma (age of onset)8e-27FLG/CCDST
GCST008916Asthma5e-27FLG/CCDST
GCST002737Atopic dermatitis2e-25CCDST-LCE5A
GCST005038Allergic disease7e-21FLG/CCDST
GCST010321PR interval3e-19FGFR1-LINC03042
GCST010796ECG morphology1e-11FGFR1
GCST008362Birth weight8e-11FGFR1-LINC03042
GCST006661Male-pattern baldness1e-10PUDPP2-RPTN
GCST007045PR interval5e-10FGFR1-LINC03042
GCST006803Schizophrenia6e-10NSD3
GCST009600Psychiatric pleiotropy2e-9FGFR1
GCST004521ASD or schizophrenia4e-9FGFR1
GCST010244Triglyceride levels4e-9FGFR1-LINC03042
GCST010988Adult body size7e-9FGFR1-LINC03042
GCST010989Body size at age 107e-9FGFR1-LINC03042
GCST090000047Age at first sexual intercourse1e-8FGFR1-LINC03042
GCST004166Nonsyndromic cleft lip/palate4e-8FGFR1
GCST010118Type 2 diabetes4e-8FGFR1-LINC03042

QUICK REFERENCE CARD ╔═══════════════════════════════════════════════════════════════════════╗ ║ FGFR1 - QUICK IDENTIFIER CARD ║ ╠═══════════════════════════════════════════════════════════════════════╣ ║ GENE ║ ║ ──── ║ ║ HGNC:3688 │ Ensembl: ENSG00000077782 ║ ║ Entrez: 2260 │ OMIM: 136350 ║ ║ Location: 8p11.23 (38,400,215-38,468,834, minus strand) ║ ╠═══════════════════════════════════════════════════════════════════════╣ ║ TRANSCRIPT (MANE Select) ║ ║ ──────────────────────── ║ ║ RefSeq: NM_023110.3 │ Ensembl: ENST00000447712 ║ ║ CCDS: CCDS6107 │ Exons: 18 ║ ╠═══════════════════════════════════════════════════════════════════════╣ ║ PROTEIN ║ ║ ─────── ║ ║ UniProt: P11362 (reviewed) │ RefSeq: NP_075598 ║ ║ Length: 822 aa │ MW: 91,868 Da ║ ╠═══════════════════════════════════════════════════════════════════════╣ ║ STRUCTURES ║ ║ ────────── ║ ║ PDB entries: 81 │ AlphaFold: AF-P11362-F1 ║ ╠═══════════════════════════════════════════════════════════════════════╣ ║ KEY NUMBERS ║ ║ ─────────── ║ ║ Transcripts: 73 │ Pathways: 22 │ GO terms: 86 ║ ║ ClinVar: 1,366+ │ Interactions: 4k+ │ Drugs (Ph4): 23+ ║ ╠═══════════════════════════════════════════════════════════════════════╣ ║ PRIMARY DISEASES ║ ║ ──────────────── ║ ║ • Pfeiffer syndrome (craniosynostosis) ║ ║ • Kallmann syndrome / Hypogonadotropic hypogonadism ║ ║ • Osteoglophonic dysplasia ║ ║ • FGFR1-rearranged myeloid/lymphoid neoplasms ║ ╠═══════════════════════════════════════════════════════════════════════╣ ║ FDA-APPROVED FGFR INHIBITORS ║ ║ ──────────────────────────── ║ ║ Erdafitinib • Infigratinib • Pemigatinib • Futibatinib ║ ╚═══════════════════════════════════════════════════════════════════════╝


Document generated: 2026-04-01 Data sources: HGNC, Ensembl, NCBI, UniProt, PDB, AlphaFold, ClinVar, AlphaMissense, SpliceAI, Reactome, GO, STRING, IntAct, ChEMBL, PharmGKB, Bgee, SCXA, GenCC, Orphanet, HPO, GWAS Catalog, CollecTRI I’ve compiled a comprehensive cross-database reference for human FGFR1 covering all 12 sections. Key highlights: Summary Statistics:

  • 73 transcripts (38 protein-coding) with MANE Select: NM_023110/ENST00000447712
  • 21 UniProt entries with canonical P11362 (822 aa, 91.9 kDa)
  • 81 PDB structures (most X-ray of kinase domain with inhibitors)
  • 1,366+ ClinVar variants with ~100 pathogenic/likely pathogenic
  • 5,386 AlphaMissense predictions for missense variants
  • 22 Reactome pathways (4 disease-related)
  • 86 GO terms across biological process, molecular function, and cellular component
  • 4,000+ STRING interactions and 232+ IntAct curated interactions
  • 23+ FDA-approved drugs that target FGFR1 (including erdafitinib, pemigatinib, futibatinib)
  • Ubiquitous expression (292/294 conditions positive) with highest in connective tissue/vasculature
  • 5 definitive disease associations: Pfeiffer syndrome, HH2/Kallmann, osteoglophonic dysplasia, Hartsfield syndrome, encephalocraniocutaneous lipomatosis